Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial

Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective

(2011) David Brooks   Neuropsychiatric Disease and Treatment

Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study

(2010) Fabrizio Stocchi et al.   ANNALS OF NEUROLOGY

When Do Levodopa Motor Fluctuations First Appear in Parkinson’s Disease

(2010) Fabrizio Stocchi et al.   EUROPEAN NEUROLOGY

Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo®)

(2010) Paolo Solla   Neuropsychiatric Disease and Treatment

Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson’s disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study

(2009) Karla Eggert et al.   JOURNAL OF NEURAL TRANSMISSION

Validation of the “QUICK” questionnaire-A tool for diagnosis of “wearing-off” in patients with Parkinson's disease

(2008) Pablo Martinez-Martin et al.   MOVEMENT DISORDERS

Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone

(2008) Victor S.C. Fung et al.   MOVEMENT DISORDERS

Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease

(2008) Robert A. Hauser et al.   MOVEMENT DISORDERS